Potential COVID-19 vaccine produced at Catalent’s Madison facility

Catalent, Inc.’s biomanufacturing facility in Madison.
Catalent, Inc.’s biomanufacturing facility in Madison.
As researchers race to develop a vaccine for COVID-19, production on one potential single-shot vaccine is underway at Catalent, Inc.’s biomanufacturing facility in Madison. Somerset, New Jersey-based Catalent and San Diego-based Arcturus Therapeutics Holdings Inc.…

Want to Read More?

Paid BizTimes subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Get our email updates

Lauren Anderson
Lauren Anderson covers health care, nonprofits, education and insurance for BizTimes. Lauren previously reported on education for the Waukesha Freeman. She graduated from the University of Wisconsin-Madison, where she studied journalism, history and African studies. In her free time, Lauren enjoys spending time with family and friends and seeing live music wherever she can.

No posts to display